Rekvina Laboratories Ltd
BSE: 526075
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 0.67-7.6% | 0.72+109.4% | 0.35+76.1% | 0.20 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.67-7.6% | 0.72+109.4% | 0.35+76.1% | 0.20 | 0.00 | 0.00 |
| EXPENSES | ||||||
| Expenditure | 0.79+0.6% | 0.78+67.0% | 0.47+103.2% | 0.23+552.8% | 0.04-17.3% | 0.04 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PROFIT | ||||||
| PBT | -0.12-99.2% | -0.06+51.2% | -0.12-255.0% | -0.03+1.4% | -0.04+17.3% | -0.04 |
| Net Profit | -0.12-99.2% | -0.06+51.2% | -0.12-255.0% | -0.03+1.4% | -0.04+17.3% | -0.04 |
| KEY METRICS | ||||||
| OPM % | -18.03%-9.67pp | -8.36%+27.49pp | -35.85%-18.06pp | -17.79% | — | — |
| NPM % | -18.03%-9.67pp | -8.36%+27.49pp | -35.85%-18.06pp | -17.79% | — | — |
| EPS | 0.20+100.0% | 0.10-52.4% | 0.21+250.0% | 0.06 | 0.00-100.0% | 0.07 |
Corporate Events
Board MeetingVINRKLB
202613Aug
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingVINRKLB
202624Jun
Board Meeting
The meeting of the Committee of Independent Directors was he…
BSE Filing ↗ Board MeetingVINRKLB
202621May
Board Meeting
To consider and approve Audited Standalone Financial Results…
BSE Filing ↗ Board MeetingVINRKLB
202616Mar
Board Meeting
To consider and approve the proposal for issuance of equity …
BSE Filing ↗ Board MeetingVINRKLB
20242Sep
Board Meeting
Consider And Approve Change Of Director, Consider And Approv…
BSE Filing ↗ Board MeetingVINRKLB
202430Aug
Board Meeting
To Consider And Approve Change Of Director, To Consider And …
BSE Filing ↗ Board MeetingVINRKLB
202429May
Board Meeting
Consider, approve and take on record Audited Standalone Fina…
BSE Filing ↗